160 related articles for article (PubMed ID: 36607434)
1. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study.
Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H
Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434
[TBL] [Abstract][Full Text] [Related]
2. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
[TBL] [Abstract][Full Text] [Related]
3. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
Zhang L; San Valentin EMD; John TM; Jenq RR; Do KA; Hanna EY; Peterson CB; Reyes-Gibby CC
Cancer; 2024 Jan; 130(1):150-161. PubMed ID: 37688396
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
5. From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis.
Bruno JS; Al-Qadami GH; Laheij AMGA; Bossi P; Fregnani ER; Wardill HR
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175980
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Hes C; Desilets A; Tonneau M; El Ouarzadi O; De Figueiredo Sousa M; Bahig H; Filion É; Nguyen-Tan PF; Christopoulos A; Benlaïfaoui M; Derosa L; Alves Costa Silva C; Ponce M; Malo J; Belkad W; Charpentier D; Aubin F; Hamilou Z; Jamal R; Messaoudene M; Soulières D; Routy B
Oral Oncol; 2024 Jan; 148():106623. PubMed ID: 38006691
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
9. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer.
Vesty A; Gear K; Biswas K; Mackenzie BW; Taylor MW; Douglas RG
Support Care Cancer; 2020 Jun; 28(6):2683-2691. PubMed ID: 31650293
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Intensity-Modulated Radiotherapy to the Head and Neck Region on the Oral Innate Immune Response and Oral Microbiome: A Prospective Cohort Study of Head and Neck Tumour Patients.
Mojdami ZD; Barbour A; Oveisi M; Sun C; Fine N; Saha S; Marks C; Elebyary O; Watson E; Tenenbaum H; Azarpazhooh A; Glogauer M
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076990
[TBL] [Abstract][Full Text] [Related]
14. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
16. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
17. Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma.
Jiang R; Liu Y; Zhang H; Chen Y; Liu T; Zeng J; Nie E; Chen S; Tan J
Front Cell Infect Microbiol; 2022; 12():1070322. PubMed ID: 36605128
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 nanoemulgel in prevention of radiation-induced oral mucositis and its associated effect on microbiome: a randomized clinical trial.
Morsy BM; El Domiaty S; Meheissen MAM; Heikal LA; Meheissen MA; Aly NM
BMC Oral Health; 2023 Aug; 23(1):612. PubMed ID: 37648997
[TBL] [Abstract][Full Text] [Related]
20. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Małecka-Massalska T
Cancer Biomark; 2018; 22(4):657-667. PubMed ID: 29865035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
